BioAge Labs, Inc. (BIOA) short interest & options flow
NASDAQBIOA enters August as one of the week's most dramatic single-stock stories — down 58% in five sessions and 64% in a single day, a collapse that rewrites the entire investment thesis around its lead drug BGE-102. The scale of the move demands a catalyst read first. The stock had been a momentum darling: a prior note recorded an extraordinary relative-strength score and analyst…
- Market cap
- $266M
- Next earnings
- 12 Nov 2026
Key data as of 11 Nov 2026

BIOA news and analysis
RSSNo long-form analysis yet for BIOA. Pulse alerts and the live data picture are available on ORTEX.
Open BIOA on ORTEX →Want the live picture for BIOA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BIOA — free to start on ORTEX.
Sign up for free →Open BIOA on ORTEX